Clinical Trials Logo

Kidney Stone clinical trials

View clinical trials related to Kidney Stone.

Filter by:

NCT ID: NCT03193177 Completed - Chronic Disease Clinical Trials

A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases

Start date: June 20, 2017
Phase:
Study type: Observational

Effectiveness of fasting or fasting-mimicking diet has been proved an effective approach to treat metabolic and autoimmune diseases in mice. However, clinical trials performing prolonged fasting with more than 7 days have not been reported. Investigators conduct an open label, phase I/II clinical trial to evaluate the safety and effectiveness of the 21-day fasting-like diet in the treatment of metabolic and autoimmune diseases.

NCT ID: NCT03111381 Completed - Pain, Postoperative Clinical Trials

Toradol to Reduce Ureteroscopic Symptoms Trial

TRUST
Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

Double blinded randomized controlled clinical trial to assess the impact of intraoperative Toradol on post-operative pain scores for patients undergoing ureteroscopy for urinary stone management.

NCT ID: NCT02818140 Completed - Kidney Stone Clinical Trials

Ultrasound-guided Transmuscular Quadratus Lumborum Block for Percutaneous Nephrolithotomy

Start date: July 2016
Phase: Phase 4
Study type: Interventional

Patients undergoing percutaneous nephrolithotomy (PNL) suffer from acute postoperative pain, despite a multimodal analgesic regime. We hypothesize that active (ropivacaine) transmuscular quadratus lumborum (TQL) block will significantly reduce postoperative opioid consumption and pain following PNL operation compared with placebo (saline) TQL block. The aim of this study is to investigate the effect of ultrasound-guided (USG) TQL block concurrent with a multimodal analgesic regime compared to the multimodal analgesic regime alone (and placebo TQL block) in a randomized and placebo controlled design.

NCT ID: NCT01928108 Completed - Kidney Stone Clinical Trials

Fluid Intake Application to Reduce Kidney Stone Risks

Start date: July 2013
Phase: N/A
Study type: Observational

The purpose of this investigation is to prospectively evaluate the benefit of different methods of educating patients regarding their fluid intake through a readily available daily cellular phone application to improve overall urine output and reduce risk factors for stone recurrence.

NCT ID: NCT01852669 Completed - Kidney Stone Clinical Trials

Adjunct Inversion for Lower Pole Stone

Start date: January 2002
Phase: N/A
Study type: Interventional

This is a randomized controlled trial comparing extracorporeal shockwave lithotripsy (ESWL) with and without simultaneous adjunct controlled inversion therapy in the treatment of lower pole caliceal stone.

NCT ID: NCT00762424 Completed - Kidney Stone Clinical Trials

Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis

Flowmax
Start date: June 2007
Phase: N/A
Study type: Interventional

Tamsulosin (Flowmax)is approved by the FDA for the treatment for enlarged prostate. Several studies regarding the use of Tamsulosin for the treatment of lower kidney stones have been carried out in the non-Emergency Department setting. This study will compare Tamsulosin 0.4 mg with placebo in regards to rate and time of stone passing and will also look at amount of pain. The purpose of this study is to compare the usefulness of Tamsulosin versus placebo on time to stone passage and pain relief in Emergency Department patients with kidney stones.

NCT ID: NCT00504283 Completed - Kidney Stone Clinical Trials

An Analgesia Protocol for Acute Renal Colic in the Emergency Department

Start date: February 2007
Phase: N/A
Study type: Interventional

An analgesia protocol for acute renal colic will lead to faster significant reductions in pain than prior practice.

NCT ID: NCT00428428 Completed - Kidney Stone Clinical Trials

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract

Start date: February 2007
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to examine the effect of endoluminally administrated isoproterenol on pelvic pressure increase during flexible ureterorenoscopy in 14 humans. We propose that isoproterenol has potential of reducing intrarenal pressure during ureterorenoscopies. Lower intrarenal pressures may have the advantage of facilitating the procedure and reducing intraoperative complications as bleeding and infections.

NCT ID: NCT00289120 Completed - Kidney Stone Clinical Trials

Effect of Cola on Urinary Stone Risk Factors

Start date: November 2003
Phase: N/A
Study type: Interventional

Examine the effects of cola on risks of kidney stones